GUARDIGLI, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 2.760
AS - Asia 1.623
EU - Europa 876
SA - Sud America 343
AF - Africa 39
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.647
Nazione #
US - Stati Uniti d'America 2.688
SG - Singapore 730
CN - Cina 432
BR - Brasile 294
IT - Italia 184
DE - Germania 181
HK - Hong Kong 171
UA - Ucraina 138
VN - Vietnam 104
GB - Regno Unito 96
TR - Turchia 73
FI - Finlandia 53
SE - Svezia 46
RU - Federazione Russa 42
CA - Canada 32
MX - Messico 31
FR - Francia 30
IN - India 23
AR - Argentina 21
ID - Indonesia 21
PL - Polonia 19
NL - Olanda 18
ZA - Sudafrica 18
ES - Italia 16
JP - Giappone 16
BD - Bangladesh 15
LT - Lituania 12
IQ - Iraq 11
CO - Colombia 9
BE - Belgio 7
DK - Danimarca 7
UZ - Uzbekistan 7
AT - Austria 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 4
EC - Ecuador 4
EG - Egitto 4
IE - Irlanda 4
NZ - Nuova Zelanda 4
VE - Venezuela 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
KE - Kenya 3
AL - Albania 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
JO - Giordania 2
PE - Perù 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.647
Città #
Singapore 391
Ashburn 352
Woodbridge 210
Santa Clara 183
Chandler 174
Hong Kong 169
Fairfield 167
Jacksonville 150
Beijing 130
Houston 129
Ann Arbor 88
Wilmington 76
Munich 74
Seattle 71
New York 56
Dallas 53
Los Angeles 53
Nanjing 52
Cambridge 46
Princeton 44
Izmir 43
São Paulo 33
Shanghai 31
Ho Chi Minh City 30
Boardman 28
Hanoi 27
Milan 26
San Diego 26
Mexico City 25
Ferrara 24
Bologna 21
London 20
Bremen 19
Buffalo 17
Denver 17
Stockholm 17
Warsaw 17
Turku 16
Brooklyn 15
Chicago 15
Tokyo 15
Phoenix 14
Shenyang 14
Atlanta 13
Hefei 13
Jakarta 13
Orem 12
Falls Church 11
Johannesburg 10
Montreal 10
Düsseldorf 9
Naples 9
The Dalles 9
Changsha 8
Jiaxing 8
Moscow 8
Nanchang 8
Rio de Janeiro 8
Tianjin 8
Toronto 8
Belo Horizonte 7
Brussels 7
Council Bluffs 7
Dearborn 7
Hebei 7
Helsinki 7
Lauterbourg 7
Poplar 7
Rome 7
San Francisco 7
Tashkent 7
Acireale 6
Boston 6
Falkenstein 6
Goiânia 6
Kunming 6
New Delhi 6
Nuremberg 6
Odense 6
Redwood City 6
Addison 5
Chennai 5
Da Nang 5
Erbil 5
Fortaleza 5
Jinan 5
Manchester 5
Modena 5
Parma 5
San Mateo 5
Ancona 4
Ankara 4
Bogotá 4
Brasília 4
Calgary 4
Campina Grande 4
Charlotte 4
Columbus 4
Haiphong 4
Ningbo 4
Totale 3.564
Nome #
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 199
Reperfusion Damage - A Story of Success, Failure, and Hope 170
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 168
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 164
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 158
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 154
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 152
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 148
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 148
Bradykinin and coronary artery disease 145
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 143
A modern fairy tale 141
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 141
Angiotensin II overproduction: enemy of the vessel wall 138
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 134
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 133
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 131
Oxidative stress during myocardial ischaemia and heart failure 130
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 129
The heart rate story 129
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 127
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 126
Tirofiban: A critical reappraisal of the clinical use, recent developments and future perspectives 123
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 121
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 119
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 118
Ferrara VI 114
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 111
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 111
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 110
Safety and efficacy of new-generation coronary bioresorbable scaffolds 105
FERRARA: CITTÀ DELLA PREVENZIONE 103
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 103
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 100
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 100
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 96
LEFT VENTRICULAR REMODELLING AT THE LIMITS 95
Ferrara II 91
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 90
Multimodality imaging in acromegalic cardiomiopathy: a case report 84
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 75
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 75
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 73
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 68
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 65
One-year outcome of elderly patients with endocarditis: a retrospective observational study 64
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 61
null 61
The future of cardiovascular prevention: between fiction and reality 59
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 28
Totale 5.731
Categoria #
all - tutte 30.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 463
Totale 30.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 28 3 38 7 35 39 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/20251.326 23 35 87 71 162 127 44 53 270 126 177 151
2025/20261.928 397 155 276 474 565 61 0 0 0 0 0 0
Totale 5.731